Abstract: Disclosed are methods of treating subjects having conditions related to angiogenesis including administering an effective amount of a polymeric form of thyroid hormone, or an antagonist thereof, to promote or inhibit angiogenesis in the subject. Compositions of the polymeric forms of thyroid hormone, or thyroid hormone analogs, are also disclosed.
Type:
Grant
Filed:
September 15, 2004
Date of Patent:
August 31, 2010
Assignees:
Ordway Research Institute, Inc., Albany College of Pharmacy
Inventors:
Shaker A. Mousa, Faith B. Davis, Paul J. Davis